HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by el Kharroubi, A. Articles by Verdin, E. Search for Related Content PubMed PubMed Citation Articles by el Kharroubi, A. Articles by Verdin, E. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 31, 19916-19924, 08, 1994

Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter

A el Kharroubi and E Verdin
Laboratory of Viral and Molecular Pathogenesis, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.

We have examined by in vitro footprinting a region located downstream of the human immunodeficiency virus, type 1 (HIV-1) promoter found to be hypersensitive to DNase I digestion in vivo. Recognition sites for several constitutive or inducible DNA binding factors were identified. Three AP-1 binding sites and an AP-3-like motif were situated within the R-U5 region of the long terminal repeat. A novel purine-rich motif (5'-GAAAGC-GAAAGDD-3' (D represents G, A, or T residues)), which interacts with a nuclear factor designated downstream binding factor 1 (DBF1), and two juxtaposed Sp-1 binding sites were located in the untranslated sequence immediately downstream of the 5'-long terminal repeat. Genomic footprinting of these sequence elements in the HIV-1 chronically infected cell lines revealed that the DBF1 and Sp-1 sites are occupied in vivo. Furthermore, transient transfection assays showed that point mutations in the DBF1 binding site decreased significantly the HIV-1 basal promoter activity. Taken together, these results suggest that the DBF1 play a role in the HIV-1 transcription regulation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. SGARBANTI, G. MARSILI, A. L. REMOLI, B. RIDOLFI, E. STELLACCI, A. BORSETTI, B. ENSOLI, and A. BATTISTINI Analysis of the Signal Transduction Pathway Leading to Human Immunodeficiency Virus-1-Induced Interferon Regulatory Factor-1 Upregulation Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 187 - 195. [Abstract] [Full Text] [PDF]

				A. C. Logan, D. L. Haas, T. Kafri, and D. B. Kohn Integrated Self-Inactivating Lentiviral Vectors Produce Full-Length Genomic Transcripts Competent for Encapsidation and Integration J. Virol., August 15, 2004; 78(16): 8421 - 8436. [Abstract] [Full Text] [PDF]

				G. MARSILI, A. BORSETTI, M. SGARBANTI, A. L. REMOLI, B. RIDOLFI, E. STELLACCI, B. ENSOLI, and A. BATTISTINI On the Role of Interferon Regulatory Factors in HIV-1 Replication Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 29 - 42. [Abstract] [Full Text] [PDF]

				O. Rohr, C. Marban, D. Aunis, and E. Schaeffer Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells J. Leukoc. Biol., November 1, 2003; 74(5): 736 - 749. [Abstract] [Full Text] [PDF]

				J. J. Coull, G. He, C. Melander, V. C. Rucker, P. B. Dervan, and D. M. Margolis Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides J. Virol., October 25, 2002; 76(23): 12349 - 12354. [Abstract] [Full Text] [PDF]

				M. Sgarbanti, A. Borsetti, N. Moscufo, M. C. Bellocchi, B. Ridolfi, F. Nappi, G. Marsili, G. Marziali, E. M. Coccia, B. Ensoli, et al. Modulation of Human Immunodeficiency Virus 1 Replication by Interferon Regulatory Factors J. Exp. Med., May 20, 2002; 195(10): 1359 - 1370. [Abstract] [Full Text] [PDF]

				L. A. Pereira, K. Bentley, A. Peeters, M. J Churchill, and N. J. Deacon SURVEY AND SUMMARY A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter Nucleic Acids Res., February 1, 2000; 28(3): 663 - 668. [Abstract] [Full Text] [PDF]

				F. Uchiumi, T. Sato, and S.-i. Tanuma Identification and Characterization of a Tannic Acid-responsive Negative Regulatory Element in the Mouse Mammary Tumor Virus Promoter J. Biol. Chem., May 15, 1998; 273(20): 12499 - 12508. [Abstract] [Full Text] [PDF]

				A. El Kharroubi, G. Piras, R. Zensen, and M. A. Martin Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter Mol. Cell. Biol., May 1, 1998; 18(5): 2535 - 2544. [Abstract] [Full Text]

				P. L. Sheridan, T. P. Mayall, E. Verdin, and K. A. Jones Histone acetyltransferases regulate HIV-1 enhancer activity in vitro Genes & Dev., December 15, 1997; 11(24): 3327 - 3340. [Abstract] [Full Text] [PDF]

				P. Widlak, R. B. Gaynor, and W. T. Garrard In Vitro Chromatin Assembly of the HIV-1 Promoter. ATP-DEPENDENT POLAR REPOSITIONING OF NUCLEOSOMES BY Sp1 AND NFkappa B J. Biol. Chem., July 11, 1997; 272(28): 17654 - 17661. [Abstract] [Full Text] [PDF]

				M J Pazin, P L Sheridan, K Cannon, Z Cao, J G Keck, J T Kadonaga, and K A Jones NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes & Dev., January 1, 1996; 10(1): 37 - 49. [Abstract] [PDF]

				P L Sheridan, C T Sheline, K Cannon, M L Voz, M J Pazin, J T Kadonaga, and K A Jones Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes & Dev., September 1, 1995; 9(17): 2090 - 2104. [Abstract] [PDF]